Tailored Communication to Reduce Cardiovascular Risk
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01286311|
Recruitment Status : Completed
First Posted : January 31, 2011
Results First Posted : February 9, 2015
Last Update Posted : February 9, 2015
|Condition or disease||Intervention/treatment||Phase|
|Hypercholesterolemia Coronary Artery Disease Dyslipidemia Hypertension||Behavioral: Direct-to-patient tailored cardiovascular risk message system||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||464 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Tailored Communication to Reduce Cardiovascular Risk|
|Study Start Date :||January 2011|
|Actual Primary Completion Date :||January 2013|
|Actual Study Completion Date :||January 2013|
Experimental: Direct-to-patient tailored cardiovascular risk message system
Eligible patients cared for by physicians randomized to the active intervention group will be mailed a tailored cardiovascular risk message.
Behavioral: Direct-to-patient tailored cardiovascular risk message system
Patient informational mailings
|No Intervention: Control|
- Comparative Outcomes: Intervention Group LDL Reduction Compared to Control Group LDL Reduction [ Time Frame: 9 months ]Significant LDL cholesterol reduction at 9 months Definition: Percentage of patients with LDL-C repeated and which is at least 30 mg/dl lower than baseline
- Frequency of Clinical Encounters [ Time Frame: 9 months ]This will measure the difference in frequency of clinical encounters in the electronic medical record.
- Medication Prescriptions for Dyslipidemia [ Time Frame: 9 months ]This will look at whether lipid lowering medications (LLM) were prescribed for dyslipidemia.
- Percentage of Patients With Uncontrolled Hypertension Who Had an Increase in the Number of Antihypertensive Medication Drug Classes Prescribed [ Time Frame: 9 months ]This will measure the percentage of participants who had uncontrolled hypertension at baseline who had an increase in the number of antihypertensive medication drug classes prescribed within 9 months.
- Presence of an Aspirin Prescription [ Time Frame: 9 months ]This will measure the presence of an aspirin prescriptions on the medication list in the electronic medical record.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01286311
|United States, Illinois|
|Northwestern Medical Faculty Foundation General Internal Medicine Ambulatory Clinic|
|Chicago, Illinois, United States, 60611|
|Principal Investigator:||Stephen Persell, MD, MPH||Northwestern University Division of General Internal Medicine, Feinberg School of Medicine and Institute for Healthcare Studies|